Overview

Ziwig Endotest® saliva test (Endometriosis clarification)

Clinical information

Ziwig Endotest® enables the diagnosis of endometriosis with a reliability of over 95 %[1,6]. Using a simple saliva sample, the expression pattern of 109 different micro-RNAs involved in the development of endometriosis is examined. Ziwig Endotest® uses the two cutting-edge technologies of high-throughput sequencing and artificial intelligence.

Intended use:
Ziwig Endotest® has been validated and approved for patients aged from 18 to 43 who exhibit symptoms that indicate endometriosis[9]:

- chronic pelvic pain
- +/- dysmenorrhea
- +/- deep dyspareunia
- +/- painful dysuria/miction
- +/- painful dyschezia/defecation
- +/- painful rectal bleeding or haematuria during menstruation
- +/- pain in the shoulder tip
- +/- infertility

Ziwig Endotest® may be useful in the following situations:
- Patients with suspected endometriosis following normal or inconclusive results of diagnostic imaging.
- Patients with persistent endometriosis symptoms despite medical treatment and normal or inconclusive results of diagnostic imaging.

Exclusions:
Endometrioma and endometriosis of the rectosigmoid, identified using ultrasound or an MRI scan.

Ziwig Endotest® requires a medical prescription. The saliva sample must be collected under the supervision of a medical specialist.

- The patient must be at least 18 years old and no older than 43 years old at the time the test is performed.
- The patient must not have any prior history of cancer or infection with the human immunodeficiency virus (HIV).
- The patient must not be pregnant at the time the test is performed.
- Ziwig Endotest® can be performed during hormone treatment.
- Ziwig Endotest® can be performed at any point in the cycle

Price: CHF 781.20

It is possible that the health insurance company will refuse to cover the costs. In this case, the patient must bear the costs herself.

Associated profile 20000.

More information

Position / Price